Filtered By:
Countries: India Health
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 321 results found since Jan 2013.
Medical Education, Practice, and Regulation of Acupuncture in India
Med Acupunct. 2022 Oct 1;34(5):294-298. doi: 10.1089/acu.2022.0008. Epub 2022 Oct 17.ABSTRACTAcupuncture is one of the most-utilized forms of integrative medicine therapy across the globe, owing to this modality's wide range of therapeutic benefits. The history of acupuncture use in India is 3000 years old; however, the first documented use of acupuncture in India emerged in 1959. Presently, acupuncture is included as an independent therapy in the yoga and naturopathy (Y&N) category, an indigenous system of medicine under the purview of the Ministry of Ayurveda, Y&N, Unani (Perso-Arabic Medicine), Sidha (Indian Med...
Source: Acupuncture in Medicine - October 31, 2022 Category: Complementary Medicine Authors: Pradeep M K Nair Mamta Jagwani Gita Sharma Deepika Singh Hemanshu Sharma Gulab Rai Tewani Source Type: research
In search for a panacea for coronavirus disease-19: Analysis of ongoing clinical trials for the management of coronavirus disease-19 pandemic in India
CONCLUSIONS: In response to the COVID-19 pandemic, Indian researchers came forward from all the systems of medicine to evaluate interventions for prophylaxis or treatment of the disease. The involvement of AYUSH systems of medicine was specifically more in this regard. A wide variation and heterogeneity in doses and outcomes were observed in trial designs which might make it difficult to generalize the study results when they are made available. Urgent analyses of studies involving interventions on the treatment advisory of the Government may help the healthcare providers take more informed decisions for managing COVID-19 patients in India.
Source: Indian Journal of Pharmacology - October 6, 2022 Category: Drugs & Pharmacology Authors: Nidhi Maheshwari Vandana Roy Source Type: research
Individualized Homeopathic Medicines in the Treatment of Tinea Corporis: Double-Blind, Randomized, Placebo-Controlled Trial
CONCLUSION: Results were negative on the primary outcome; however, secondary outcomes included some statistically significant results favoring IHMs against placebo after 3 months.TRIAL REGISTRATION: CTRI/2019/11/021999; UTN: U1111-1242-0070.PMID:36122589 | DOI:10.1055/s-0042-1750799
Source: Homeopathy - September 19, 2022 Category: Complementary Medicine Authors: Bakibillah Laskar Swapan Paul Abhijit Chattopadhyay Avaranjika Karuppusamy Dharshna Balamurugan Puja Bhakta Sourav Das Siddhartha Pal Navin Kumar Singh Munmun Koley Subhranil Saha Source Type: research
Individualized Homeopathic Medicines in Treatment of Hyperuricemia: Evaluation by Double-Blind, Randomized, Placebo-Controlled Trial
CONCLUSION: IHMs showed significantly better results than placebos in reducing SUA levels and improving quality of life in patients suffering from HU.TRIAL REGISTRATION: CTRI/2019/10/021503; UTN: U1111-1241-1431.PMID:36122588 | DOI:10.1055/s-0042-1751272
Source: Homeopathy - September 19, 2022 Category: Complementary Medicine Authors: Priyanka Ghosh Subhasish Ganguly Shyamal Kumar Mukherjee Souvik Dutta Abdur Rahaman Shaikh Sk Swaif Ali Navin Kumar Singh Pulakendu Bhattacharya Munmun Koley Subhranil Saha Source Type: research
Individualized Homeopathic Medicines in the Treatment of Tinea Corporis: Double-Blind, Randomized, Placebo-Controlled Trial
CONCLUSION: Results were negative on the primary outcome; however, secondary outcomes included some statistically significant results favoring IHMs against placebo after 3 months.TRIAL REGISTRATION: CTRI/2019/11/021999; UTN: U1111-1242-0070.PMID:36122589 | DOI:10.1055/s-0042-1750799
Source: Homeopathy - September 19, 2022 Category: Complementary Medicine Authors: Bakibillah Laskar Swapan Paul Abhijit Chattopadhyay Avaranjika Karuppusamy Dharshna Balamurugan Puja Bhakta Sourav Das Siddhartha Pal Navin Kumar Singh Munmun Koley Subhranil Saha Source Type: research
Individualized Homeopathic Medicines in Treatment of Hyperuricemia: Evaluation by Double-Blind, Randomized, Placebo-Controlled Trial
CONCLUSION: IHMs showed significantly better results than placebos in reducing SUA levels and improving quality of life in patients suffering from HU.TRIAL REGISTRATION: CTRI/2019/10/021503; UTN: U1111-1241-1431.PMID:36122588 | DOI:10.1055/s-0042-1751272
Source: Homeopathy - September 19, 2022 Category: Complementary Medicine Authors: Priyanka Ghosh Subhasish Ganguly Shyamal Kumar Mukherjee Souvik Dutta Abdur Rahaman Shaikh Sk Swaif Ali Navin Kumar Singh Pulakendu Bhattacharya Munmun Koley Subhranil Saha Source Type: research
Individualized Homeopathic Medicines in the Treatment of Tinea Corporis: Double-Blind, Randomized, Placebo-Controlled Trial
CONCLUSION: Results were negative on the primary outcome; however, secondary outcomes included some statistically significant results favoring IHMs against placebo after 3 months.TRIAL REGISTRATION: CTRI/2019/11/021999; UTN: U1111-1242-0070.PMID:36122589 | DOI:10.1055/s-0042-1750799
Source: Homeopathy - September 19, 2022 Category: Complementary Medicine Authors: Bakibillah Laskar Swapan Paul Abhijit Chattopadhyay Avaranjika Karuppusamy Dharshna Balamurugan Puja Bhakta Sourav Das Siddhartha Pal Navin Kumar Singh Munmun Koley Subhranil Saha Source Type: research
Individualized Homeopathic Medicines in Treatment of Hyperuricemia: Evaluation by Double-Blind, Randomized, Placebo-Controlled Trial
CONCLUSION: IHMs showed significantly better results than placebos in reducing SUA levels and improving quality of life in patients suffering from HU.TRIAL REGISTRATION: CTRI/2019/10/021503; UTN: U1111-1241-1431.PMID:36122588 | DOI:10.1055/s-0042-1751272
Source: Homeopathy - September 19, 2022 Category: Complementary Medicine Authors: Priyanka Ghosh Subhasish Ganguly Shyamal Kumar Mukherjee Souvik Dutta Abdur Rahaman Shaikh Sk Swaif Ali Navin Kumar Singh Pulakendu Bhattacharya Munmun Koley Subhranil Saha Source Type: research
Individualized Homeopathic Medicines in the Treatment of Tinea Corporis: Double-Blind, Randomized, Placebo-Controlled Trial
CONCLUSION: Results were negative on the primary outcome; however, secondary outcomes included some statistically significant results favoring IHMs against placebo after 3 months.TRIAL REGISTRATION: CTRI/2019/11/021999; UTN: U1111-1242-0070.PMID:36122589 | DOI:10.1055/s-0042-1750799
Source: Homeopathy - September 19, 2022 Category: Complementary Medicine Authors: Bakibillah Laskar Swapan Paul Abhijit Chattopadhyay Avaranjika Karuppusamy Dharshna Balamurugan Puja Bhakta Sourav Das Siddhartha Pal Navin Kumar Singh Munmun Koley Subhranil Saha Source Type: research
Individualized Homeopathic Medicines in Treatment of Hyperuricemia: Evaluation by Double-Blind, Randomized, Placebo-Controlled Trial
CONCLUSION: IHMs showed significantly better results than placebos in reducing SUA levels and improving quality of life in patients suffering from HU.TRIAL REGISTRATION: CTRI/2019/10/021503; UTN: U1111-1241-1431.PMID:36122588 | DOI:10.1055/s-0042-1751272
Source: Homeopathy - September 19, 2022 Category: Complementary Medicine Authors: Priyanka Ghosh Subhasish Ganguly Shyamal Kumar Mukherjee Souvik Dutta Abdur Rahaman Shaikh Sk Swaif Ali Navin Kumar Singh Pulakendu Bhattacharya Munmun Koley Subhranil Saha Source Type: research
Dr. Ramji Gupta: The Homeopathy Ambassador and Leading Dermatologist of India
Homeopathy. 2022 Aug 21. doi: 10.1055/s-0042-1750209. Online ahead of print.NO ABSTRACTPMID:35988580 | DOI:10.1055/s-0042-1750209
Source: Homeopathy - August 21, 2022 Category: Complementary Medicine Authors: Raj Kumar Manchanda Source Type: research
